Follow me on Twitter

I agree that content from Twitter will be displayed to me.

 

Head of Group
Director of Corporate Program

His main research interests are ligand- and structure-based drug design with focus on transmembrane transport proteins, prediction of on- and off-kinetics, as well as semantic data integration.

Contact Hours for Students

  • Wednesday 14:00 - 15:00
  • Room 2E405 (or online) 
  • only after appointment via E-Mail latest on Friday before
Publications

Showing entries 1 - 5 out of 307
Dvorak, V, Casiraghi, A, Colas, C, Koren, A, Tomek, T, Offensperger, F, Rukavina, A, Tin, G, Hahn, E, Dobner, S, Frommelt, F, Boeszoermenyi, A, Bernada, V, Hannich, JT, Ecker, GF, Winter, GE, Kubicek, S & Superti-Furga, G 2023, 'Paralog-dependent isogenic cell assay cascade generates highly selective SLC16A3 inhibitors', Cell Chemical Biology, vol. 30, no. 8, pp. 953-964.e9. https://doi.org/10.1016/j.chembiol.2023.06.029

Activities

In silico models for classification of ABC-transporter substrates to improve ADMET profiling

Gerhard Ecker
6th Joint Meeting on Medicinal Chemistry (EFMC)
Conference, Talk or oral contribution
27.6.2009 - 27.6.2009

Pharmacoinformatics – combining experimental pharmaceutical sciences with in silico methods

Gerhard Ecker
2nd Pharmaceutical Sciences Fair and Exhibition -
Other, Talk or oral contribution
9.6.2009 - 9.6.2009

Predicting substrate properties for ABC-Transporter - Safety Sciences on the molecular level

Gerhard Ecker
27th Noordwijkerhout-Camerino-Cyprus Symposium: Trends in Drug Research
Conference, Talk or oral contribution
7.5.2009 - 7.5.2009

SIBAR descriptors and support vector machines for ABCB1 substrate prediction

Gerhard Ecker
21. Wissenschaftliche Tagung der Österreichischen Pharmazeutischen Gesellschaft
Conference, Talk or oral contribution
16.4.2009 - 16.4.2009

Predicting Ligands of ABC-transporter - a long way to go

Gerhard Ecker
Talk or oral contribution
13.3.2009 - 13.3.2009